Investing Profile

Adam Wieschhaus

InvestorVC
Executive in Residence at General Inception
northpondventures.comSan Francisco, California
Photo of Adam Wieschhaus, General Inception

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
UBS Network
316 CONNECTIONS
Cowen Inc. Network
31 CONNECTIONS
Cowen Inc. Network
31 CONNECTIONS
The University of Georgia Network
23 CONNECTIONS
Northpond Ventures Network
16 CONNECTIONS
cb
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Slingshot Biosciences
Series AFeb 2023$26M
Series AJul 2021$23M
$49M
Co-investors: Corey Ritter (ARCH Venture Partners)
Vestaron
Series CAug 2022$10M
Series BFeb 2021$18M
$170M
Co-investors: Ariel Barack (Ordway Selections), Philip Austin (Anterra Capital), Martin Alexander Gershon (Endeavor Venture Funds), Karl Kerksiek (Endeavor8), Son Vo (Wilbur-Ellis [Cavallo])
Kytopen
Series ASep 2021$30M
$34M
Co-investors: Katie Rae (Project 11)
Torus Biosystems
Series AMay 2021$25M
$25M
Co-investors: David R. Walt (Arbor Biotechnologies)
Isolere Bio
SeedMay 2021$7M
$7M
Ultivue
Series DApr 2021$50M
$97M
Co-investors: Keith Crandell (ARCH Venture Partners), Leon Chen (6 Dimensions Capital), Sharon Kedar (Northpond Ventures)
Executive in Residence General Inception2024 - Present
Postdoctoral Fellow Tufts MedicinePresent
Associate, Healthcare Equity Research Cowen Inc.Present
Vice President, Healthcare Equity Research Cowen Inc.Present
Executive Director UBSPresent
Managing Director Northpond Ventures2022 - 2023
Director Northpond Ventures2021 - 2022
Vice President Northpond Ventures2020 - 2021
Vice President, Healthcare Equity Research Cowen and Company2016 - 2020
Associate, Healthcare Equity Research Cowen and Company2014 - 2016
Postdoctoral Fellow Tufts Medical Center2013 - 2014
The University of Georgia B.S. Biochemistry and Molecular Biology
University of Illinois College of Medicine Ph.D. Pharmacology
Sign in with Google →
Sign in with Google →